Frontlight ResearchEarly access
Trial site
Changhua
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia1 trial
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- Huntington's disease1 trial
- Myeloproliferative neoplasms1 trial
- Osteoarthritis1 trial
- Stroke1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Status
- Active, not recruiting2 trials
- Recruiting2 trials
- Completed1 trial
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals6 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
Active, not recruiting
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Huntington's disease1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026